Clinical Trial Details


Research Study Summary

Smoking Cessation Study


We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits.

Patient Inclusion Criteria:

  • Participants must be 18-75 and smoke at least 10 cigarettes a day.

Patient Exclusion Criteria:

  • Patients who have had an allergic reaction to a medication, have had a DUI, seizure or stroke, are not eligible to participate. In addition, there are certain medications which would exclude the patient from participating.

To Learn more

CW ID: 182300
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Both Male and Female
18 to 75 Years
Overall Status
Facility Type


Melissa Carro, Director of Marketing
Clinical Research Associates, Inc.
1500 Church Street
Nashville, TN 37203
Phone: 615-329-2222 ext. 304

View Map

Research Center Information:

Clinical Research Associates, Inc.

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.